OUR STORY
We didn't set out to be a skin care company
our story
A HOUSE OF CREATION AND KNOW-HOW
REGENERA is a skincare brand of avant-garde luxury. At the meeting point of cutting-edge science and biotech, its rich heritage is matched by its commitment to innovation. Under the uncompromising vision of Global Brand President Aurora Chisté, and in partnership with the leading doctor scientists of our time, the brand’s objective remains as it was in the beginning of beauty: to empower women and men through beauty.
Regenera believes regenerative medicine is the future of healthcare. We are passionate about figuring out innovative ways to improve our biology. We leverage technology to do amazing things in the computing world – Regenera is applying a similar discipline to advance our skin and bodies.
Regenera is committed to making skin longevity accessible to the public in clinical settings and at home, so that everyone can have healthier, younger-looking skin longer than they ever imagined was possible.
Our leadership team
Four scientists on a mission to redefine aging
Our leadership team
Four scientists on a mission to redefine aging
Carolina Reis Oliveira, PhD
OneSkin Co-Founder & CEO
Fascinated with biology from a young age, Carolina knew she’d have a future in science. A fearless leader with a passion for longevity and living life to the fullest, she embarked on an ambitious goal — to delay the onset of age-related diseases by targeting aging itself. This led her to earn degrees in stem cell biology and tissue engineering, and a doctorate in immunology. Then, determined to translate her academic achievements into real-world impact, Carolina left her native Brazil for Silicon Valley, co-founding OneSkin in 2016. As Chief Executive Officer, Carolina and her team spearhead research and development, creating molecules that target cellular aging, including their pioneering innovation, the OS-01 peptide.
Carolina Reis Oliveira, PhD
OneSkin Co-Founder & CEO
Fascinated with biology from a young age, Carolina knew she’d have a future in science. A fearless leader with a passion for longevity and living life to the fullest, she embarked on an ambitious goal — to delay the onset of age-related diseases by targeting aging itself. This led her to earn degrees in stem cell biology and tissue engineering, and a doctorate in immunology. Then, determined to translate her academic achievements into real-world impact, Carolina left her native Brazil for Silicon Valley, co-founding OneSkin in 2016. As Chief Executive Officer, Carolina and her team spearhead research and development, creating molecules that target cellular aging, including their pioneering innovation, the OS-01 peptide.
Carolina Reis Oliveira, PhD
OneSkin Co-Founder & CEO
Fascinated with biology from a young age, Carolina knew she’d have a future in science. A fearless leader with a passion for longevity and living life to the fullest, she embarked on an ambitious goal — to delay the onset of age-related diseases by targeting aging itself. This led her to earn degrees in stem cell biology and tissue engineering, and a doctorate in immunology. Then, determined to translate her academic achievements into real-world impact, Carolina left her native Brazil for Silicon Valley, co-founding OneSkin in 2016. As Chief Executive Officer, Carolina and her team spearhead research and development, creating molecules that target cellular aging, including their pioneering innovation, the OS-01 peptide.
Carolina Reis Oliveira, PhD
OneSkin Co-Founder & CEO
Fascinated with biology from a young age, Carolina knew she’d have a future in science. A fearless leader with a passion for longevity and living life to the fullest, she embarked on an ambitious goal — to delay the onset of age-related diseases by targeting aging itself. This led her to earn degrees in stem cell biology and tissue engineering, and a doctorate in immunology. Then, determined to translate her academic achievements into real-world impact, Carolina left her native Brazil for Silicon Valley, co-founding OneSkin in 2016. As Chief Executive Officer, Carolina and her team spearhead research and development, creating molecules that target cellular aging, including their pioneering innovation, the OS-01 peptide.